Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-22-031498

Chief Business Officer acquired 16,224 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hannah Brendan · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-19 Grant or award : show line 1 in the form +16,224 16,224 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-05-19 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +103,500 103,500 D
2022-05-23 Grant or award : show line 3 in the form Employee Stock Option (right to buy) +353,656 353,656 D
Loading xslF345X03/doc4.xml…